Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Net Cash Flow (2014 - 2023)

Mesoblast (MESO) posted Net Cash Flow of $22.5 million for Q2 2023, up 219.88% sequentially from -$18.8 million in Q1 2023, and up 239.23% YoY from $6.6 million in Q2 2022.

Analysis

Mesoblast (MESO) Net Cash Flow (2014 - 2023) Analysis & Trends

Mesoblast has reported Net Cash Flow for 8 years, with the latest figure at $22.5 million in Q2 2023.

  • Quarterly Net Cash Flow rose 239.23% year-over-year to $22.5 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was $22.5 million (up 252.31% YoY) and the FY2025 annual result came in at $97.5 million, up 1273.74% from the prior year.
  • Net Cash Flow grew to $22.5 million in Q2 2023 per MESO's latest filing, from -$18.8 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $81.0 million in Q1 2021 and troughed at -$31.7 million in Q4 2020.
  • A 5-year average of -$439500.0 and a median of -$18.3 million in 2022 frame the typical range for Net Cash Flow.
  • The sharpest annual moves came in 2020 and 2021: Net Cash Flow plunged 208.58% in 2020, then soared 491.98% in 2021.
  • Over 5 years, Net Cash Flow stood at $46.4 million in 2019, then sank by 168.33% to -$31.7 million in 2020, then jumped by 33.25% to -$21.2 million in 2021, then rose by 12.66% to -$18.5 million in 2022, then soared by 221.59% to $22.5 million in 2023.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $22.5 million, -$18.8 million, and -$18.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Mesoblast 2.24 Bn 2.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 149.03 Mn
Mar 31, 2023 -80.25 Mn
Dec 31, 2022 14.41 Mn
Sep 30, 2022 54.38 Mn
Jun 30, 2022 -16.16 Mn
Mar 31, 2022 -18.10 Mn
Dec 31, 2021 -21.18 Mn
Sep 30, 2021 15.95 Mn
Jun 30, 2021 -21.38 Mn
Mar 31, 2021 80.96 Mn
Dec 31, 2020 -31.73 Mn
Sep 30, 2020 -21.71 Mn
Mar 31, 2020 9.94 Mn
Dec 31, 2019 30.59 Mn
Sep 30, 2019 -15.85 Mn
Mar 31, 2019 -6.69 Mn
Dec 31, 2018 55.28 Mn
Sep 30, 2018 17.52 Mn
Jun 30, 2018 -21.64 Mn
Mar 31, 2018 12.06 Mn